Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface,
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant …

Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

INTRODUCTION The discovery of malignant cells in pleural fluid and/or parietal pleura
signifies disseminated or advanced disease and a reduced life expectancy in patients with …

Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation …

Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010 |
Thorax Skip to main content Viewing from: Google Indexer BMJ Journals Subscribe Log In More …

Malignant pleural mesothelioma (MPM) is a deadly disease that occurs in 2,000 to 3,000
people each year in the United States. Although MPM is an extremely difficult disease to …

Background The use of prophylactic radiotherapy to prevent procedure-tract metastases
(PTMs) in malignant pleural mesothelioma remains controversial, and clinical practice varies …

Background: The aim of this multicenter trial was to prospectively evaluate neo-adjuvant
chemotherapy followed by extrapleural pneumonectomy (EPP) and radiotherapy, including …

Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer that arises from the
mesothelial surface of the pleural and peritoneal cavities, the pericardium, and rarely, the …